NAGE
Niagen Bioscience, Inc.
2.70$
-2.2%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 52.7% | 59.2% | 52.0% | 50.0% | 52.1% | 49.1% | 52.2% | 50.7% | 46.3% | 48.0% | 47.2% | 43.7% | 44.0% | 43.0% | 42.1% | 40.6% | 40.4% | 39.0% | 37.1% | 38.9% | 38.9% | 38.8% | 39.0% | 40.0% | 40.2% | 42.8% | 40.1% | 39.2% | 38.6% | 39.0% | 39.3% | 39.8% | 36.5% | 37.5% | 36.6% | 35.0% | 35.5% | 35.9% | 36.5% | 35.2% | 35.8% | |
| 47.3% | 40.8% | 48.0% | 50.0% | 47.9% | 50.9% | 47.8% | 49.3% | 53.7% | 52.0% | 52.8% | 56.3% | 56.0% | 57.0% | 57.9% | 59.4% | 59.6% | 61.0% | 62.9% | 61.1% | 61.1% | 61.2% | 61.0% | 60.0% | 59.8% | 57.2% | 59.9% | 60.8% | 61.4% | 61.0% | 60.7% | 60.2% | 63.5% | 62.5% | 63.4% | 65.0% | 64.5% | 64.1% | 63.5% | 64.8% | 64.2% | |
| 19.6% | 9.5% | 19.7% | 20.2% | 17.1% | 19.3% | 21.9% | 18.1% | 16.6% | 14.1% | 11.6% | 9.6% | 8.7% | 8.7% | 6.4% | 5.9% | 5.9% | 6.4% | 5.4% | 5.7% | 5.8% | 5.9% | 6.2% | 7.4% | 7.2% | 6.1% | 5.3% | 6.7% | 6.4% | 5.5% | 9.5% | 5.8% | 5.0% | 4.5% | 4.1% | 5.0% | 5.3% | 5.1% | 4.7% | 5.1% | 5.0% | |
| 43.9% | 59.0% | 68.9% | 61.9% | 64.9% | 116.3% | 104.0% | 84.5% | 83.4% | 76.6% | 82.9% | 71.5% | 66.1% | 77.0% | 61.6% | 45.3% | 46.4% | 53.0% | 65.0% | 51.6% | 64.7% | 36.6% | 51.9% | 42.8% | 36.2% | 28.5% | 28.5% | 35.9% | 30.0% | 25.6% | 24.2% | 24.9% | 24.6% | 3.6% | 17.0% | 23.4% | 21.0% | 22.1% | 23.0% | 23.4% | 22.3% | |
| 70.8% | 78.4% | 100.7% | 112.8% | 100.1% | 167.5% | 175.7% | 151.0% | 159.6% | 142.8% | 136.1% | 121.0% | 113.1% | 124.7% | 99.0% | 83.6% | 89.2% | 100.4% | 113.0% | 92.5% | 112.2% | 91.1% | 105.8% | 98.2% | 77.8% | 64.1% | 68.7% | 72.2% | 67.3% | 61.8% | 64.0% | 61.3% | 57.2% | 38.1% | 47.8% | 54.8% | 52.1% | 57.9% | 58.5% | 62.5% | 57.6% | |
| -23.5% | -37.6% | -52.6% | -62.8% | -52.2% | -116.6% | -127.9% | -101.7% | -105.9% | -90.9% | -83.3% | -64.7% | -57.1% | -67.7% | -41.1% | -24.1% | -29.6% | -39.4% | -50.1% | -31.4% | -51.1% | -29.9% | -44.8% | -38.2% | -18.0% | -6.9% | -8.7% | -11.4% | -5.9% | -0.8% | -3.3% | -1.1% | 6.3% | 24.4% | 15.7% | 10.2% | 12.5% | 6.2% | 5.0% | 2.4% | 6.7% | |
| 0.3% | 0.5% | 1.1% | 0.9% | 0.7% | 0.6% | 0.7% | 0.6% | 0.1% | – | – | 5.2% | 2.6% | – | 0.1% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| -23.5% | -38.1% | -53.5% | -63.7% | -52.9% | -117.1% | -128.6% | -103.2% | -106.0% | -90.6% | -83.0% | -69.9% | -59.8% | -67.6% | -41.1% | -24.3% | -29.7% | -39.5% | -50.3% | -31.4% | -51.2% | -30.0% | -44.8% | -38.2% | -5.8% | -6.8% | -8.4% | -10.8% | -4.9% | 0.5% | -2.2% | -0.1% | 7.3% | 25.7% | 17.2% | 12.0% | 14.1% | 13.1% | 21.4% | 3.6% | 13.2% | |
| -0.1% | -0.1% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0% | 0.6% | 0.4% | 0.7% | 0.9% | 1.3% | 0.4% | 0.8% | |
| -24.2% | -38.0% | -57.3% | -65.5% | 35.1% | -117.1% | -128.6% | -103.2% | -106.0% | -90.6% | -83.0% | -69.9% | -59.8% | -67.6% | -41.1% | -24.3% | -29.7% | -39.5% | -50.3% | -31.4% | -51.2% | -30.0% | -44.8% | -38.2% | -5.8% | -6.8% | -8.4% | -10.8% | -4.9% | 0.5% | -2.2% | -0.1% | 7.3% | 24.6% | 16.6% | 11.6% | 13.5% | 12.2% | 20.1% | 3.2% | 12.4% | |
| -20.9% | -35.5% | -48.1% | -58.1% | -49.1% | -114.3% | -125.2% | -99.1% | -103.1% | -88.3% | -79.6% | -61.1% | -53.8% | -65.0% | -38.5% | -21.7% | -26.9% | -36.8% | -47.4% | -29.0% | -48.7% | -27.7% | -41.6% | -35.6% | -3.1% | -14.6% | -6.5% | -8.6% | -2.6% | 2.3% | -0.5% | 1.6% | 8.8% | 26.9% | 18.4% | 13.2% | 14.7% | 15.6% | 22.3% | 3.9% | 14.3% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.